Table 2.
Relationship between PITPNA-AS1 expression and clinicopathological characteristics.
| Parameters | Group | Total | PITPNA-AS1 | p-value | |
|---|---|---|---|---|---|
| expression | |||||
| High | Low | ||||
| Gender | Male | 53 | 28 | 25 | 0.787 |
| Female | 40 | 20 | 20 | ||
| Age (years) | <50 | 44 | 23 | 21 | 0.904 |
| ≥50 | 49 | 25 | 24 | ||
| Tumor size (cm) | <4 | 52 | 20 | 32 | 0.004 |
| ≥4 | 41 | 28 | 13 | ||
| Tumor differentiation | Well/Moderate | 57 | 24 | 33 | 0.021 |
| Poor | 36 | 24 | 12 | ||
| Lymph node metastasis | Absence | 65 | 28 | 37 | 0.012 |
| Presence | 28 | 20 | 8 | ||
| Clinical stage | I-II | 58 | 24 | 34 | 0.011 |
| III-IV | 35 | 24 | 11 | ||